Mobile Site ›
Print Friendly View

Test ID: CEBPA    
CEBPA Mutations, Gene Sequencing

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Initial evaluation of acute myeloid leukemia, both for assigning an appropriate diagnostic subclassification and as an aid for determining prognosis.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Mutation Detection in DNA Using Sanger Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

CEBPA Mutations, Sequencing

Aliases Lists additional common names for a test, as an aid in searching

CEBPA
CCAAT Enhancer-Binding Protein Alpha Gene
Normal Karyotype AML
AML Prognosis